We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZEK
1551
DELISTED
The AZEK Co
AZEK
$23.6M 0.01%
612,592
-160,038
-21% -$5.78M
RACE icon
1552
CALL
Ferrari
RACE
$69.2B
$23.5M 0.01%
102,600
+27,300
+36% +$5.57M
OIH icon
1553
CALL
VanEck Oil Services ETF
OIH
$2.06B
$23.5M 0.01%
152,840
-33,860
-18% -$4.3M
EW icon
1554
PUT
Edwards Lifesciences
EW
$49.6B
$23.5M 0.01%
257,600
+25,400
+11% +$2.11M
RY icon
1555
Royal Bank of Canada
RY
$291B
$23.3M 0.01%
284,484
-260,140
-48% -$20.1M
PLAY icon
1556
CALL
Dave & Buster's
PLAY
$377M
$23.3M 0.01%
776,900
-2,300
-0.3% -$51.1K
BUD icon
1557
CALL
AB InBev
BUD
$170B
$23.3M 0.01%
332,800
-53,500
-14% -$3.38M
OKE icon
1558
CALL
Oneok
OKE
$57.2B
$23.1M 0.01%
602,100
+164,600
+38% +$5.53M
TFC icon
1559
CALL
Truist Financial
TFC
$63.3B
$23.1M 0.01%
481,971
-245,129
-34% -$11.1M
ZEN
1560
DELISTED
ZENDESK INC
ZEN
$23.1M 0.01%
161,345
-81,886
-34% -$10.2M
ARWR icon
1561
Arrowhead Research
ARWR
$11.9B
$23.1M 0.01%
300,872
+34,890
+13% +$2.23M
TECX
1562
Tectonic Therapeutic
TECX
$529M
$23.1M 0.01%
137,892
-14,909
-10% -$2.65M
TTCF
1563
PUT
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$23.1M 0.01%
1,007,600
+219,200
+28% +$4.33M
TEVA icon
1564
PUT
Teva Pharmaceuticals
TEVA
$40.8B
$23M 0.01%
2,386,900
+219,700
+10% +$2.1M
ZNGA
1565
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$23M 0.01%
2,329,500
+1,080,800
+87% +$9.73M
KBH icon
1566
KB Home
KBH
$3.37B
$22.9M 0.01%
683,888
+43,592
+7% +$1.57M
XEL icon
1567
Xcel Energy
XEL
$48.8B
$22.9M 0.01%
343,843
-1,548,341
-82% -$108M
HSY icon
1568
CALL
Hershey
HSY
$35.2B
$22.9M 0.01%
150,400
-40,100
-21% -$5.93M
CERE
1569
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$22.9M 0.01%
+1,381,556
New +$17.9M
RAD
1570
PUT
DELISTED
Rite Aid Corporation
RAD
$22.9M 0.01%
1,446,920
-101,880
-7% -$1.31M
CHX
1571
DELISTED
ChampionX
CHX
$22.9M 0.01%
1,495,266
-3,302,161
-69% -$36.7M
FLGT icon
1572
PUT
Fulgent Genetics
FLGT
$470M
$22.9M 0.01%
438,600
+371,000
+549% +$15.5M
APO icon
1573
PUT
Apollo Global Management
APO
$72.4B
$22.8M 0.01%
466,500
-42,200
-8% -$1.88M
F icon
1574
Ford
F
$58.5B
$22.8M 0.01%
2,597,210
-5,542,536
-68% -$46.4M
MTB icon
1575
M&T Bank
MTB
$35.7B
$22.7M 0.01%
178,652
-116,064
-39% -$13.2M

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.